ER Editor: Zerohedge is drawing its reporting from Bloomberg (linked to below). This reporting fails to mention, curiously, the DNA-changing aspect of this vaccine’s effects within the body. Nor that, with covid having a more than 99% covid recovery rate, plus the existence of hydroxychloroquine, the drug-equivalent of a vaccine, a 90% ‘successful’ vaccine (hastily claimed without longterm testing data) isn’t even necessary.
The information below is interesting. And it makes us wonder if western governments aren’t going to be squeezed royally on the pricing for this vaccine if its global distribution is going to be drastically curtailed.
We recommend this piece from Scientific Principia International, on former Pfizer CEO Dr. Mike Yeadon‘s remarks on the total lack of safety data on this vaccine in a letter to UK Health Minister, Matt Hancock. See Top Pfizer Whistleblower Trashes Company’s Vaccine ‘Breakthrough’ Spin Author John O’Sullivan also adds the very important point: if the virus is nothing more than a CDC computer-generated virus that HASN’T BEEN ISOLATED IN ACTUAL PEOPLE, then what on earth can be in the vaccine?
“A Vaccine For The Rich” – Pfizer’s COVID-19 Jab Almost Impossible To Distribute In Poorer Countries
A logistical “roadmap” from Shanghai Fosun Pharmaceutical has been released showing the staggering logistical feats required to transport and store the Pfizer-BioNTech vaccine, which has just been christened by Bloomberg as “the vaccine of the rich”.
Offering some more insight into details that have been the subject of much speculation on Wall Street, Bloomberg reported on this “complex and costly” private network that companies are building to help distribute vaccines like Pfizer’s mRNA vaccine (a technology that’s also being used by another leading candidate, Moderna), that is, once it has finally been approved.
Countries that don’t already have these networks will need to build them from scratch if they wish to substantially reduce the supply bottleneck, which would be “a herculean task”.
That means that countries will need to build from scratch the deep-freeze production, storage and transportation networks needed for the vaccine to survive. This massive investment and coordination required all but guarantees that only rich nations will manage to dial up access, with the wealthy first in line to receive their doses.
“Its production is costly, its component is unstable, it also requires cold-chain transportation and has a short shelf life,” said Ding Sheng, director of the Beijing-based Global Health Drug Discovery Institute, which has received funding from the Bill & Melinda Gates Foundation.
The WHO and Bill Gates have invested plenty of time on a PR campaign warning that access to the vaccine must be made ‘universal’ – that is, extended to all of earth’s 7.7 billion people – or humanity won’t manage to eradicate COVID-19. Together, they’ve backed a project called ‘Covax’ which aims to raise $18 billion to pay for vaccines for poorer countries.
But even once they’ve been paid for, the task remains: how can we physically ship and store them in such vast quantities?
The massive expense of the infrastructure investment means many of these poorer countries are now faced with a difficult choice: invest in the supply network, even before the vaccines have been approved, and take a risk should unforeseen complications arise, or wait to see how everything pans out for the developed world, sacrificing valuable time. Many of these economies could simply wait longer until more conventional vaccines, using other technologies, such as Russia’s adenovirus-vector vaccine, are available. Generally speaking, mRNA vaccines are a new class of vaccines, which is why some are apprehensive about the long-term side effects, which can’t be reliably studied.
“If there is a protein-based vaccine that could achieve the same effect as an mRNA vaccine does and there’s the need to vaccinate billions of people every year, I’d go for the protein-based shots in the long run,” Ding said.
Countries like India are facing particular difficulties given that shipping regular consumer goods remains a difficult, even treacherous, process across much of the country’s hinterland. Health-care experts in the country have already dismissed sub-zero storage as completely unworkable – “just forget it, one said.”
Many working in the country’s public health and the pharmaceutical industry have already voiced concern that India lacks the necessary capacity and capability to deliver a vaccine across its vast rural hinterland and population of over 1.3 billion people at the breakneck speed now expected.
“Most of these vaccines need minus 70 degrees, which we just can’t do in India, just forget it,” said T. Sundararaman, a New Delhi-based global coordinator of the People’s Health Movement, an organization that brings together local activists, academics and civil society groups working on public health.
“Our current cold chains are not able to cope with some districts’ need for measles vaccines, and that’s only for children below the age of 3,” he said. “That’s a really trivial number of people compared to the numbers that will need a Covid-19 vaccine.”
When asked at a Tuesday briefing if India’s government would look to buy any of the Pfizer vaccine, Rajesh Bhushan, the secretary at the health ministry, said New Delhi is in talks with all vaccine manufacturers. He added that India was in a position to “augment and strengthen” its existing cold-chain capacity, but declined to release any purchase details immediately.
So, judging by the way things are going…
…it looks like the world is headed for a tiered system: one vaccine for the wealthy, and one another for the poor. (ER: Which may not be a bad thing for the poorer nations.)
Published to The Liberty Beacon from EuropeReloaded.com
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.